2,156
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients

ORCID Icon, , , , , , & ORCID Icon show all
Pages 5016-5023 | Received 22 Jun 2021, Accepted 06 Oct 2021, Published online: 29 Oct 2021

References

  • Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, De Lima Lopes G Jr., et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–18. doi:10.1016/S0140-6736(20)31187-9.32473681.
  • Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, Chackathayil J, Cheng VW, Curley HM, Fittall MW, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–26. doi:10.1016/S0140-6736(20)31173-9.32473682.
  • Corti C, Crimini E, Tarantino P, Pravettoni G, Eggermont AMM, Delaloge S, Curigliano G. SARS-CoV-2 vaccines for cancer patients: a call to action. Eur J Cancer. 2021;148:316–27. doi:10.1016/j.ejca.2021.01.046.33770576.
  • Giesen N, Sprute R, Ruthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, et al. 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. Eur J Cancer. 2021;147:154–60. doi:10.1016/j.ejca.2021.01.033.33676266.
  • Thompson HS, Manning M, Mitchell J, Kim S, Harper FWK, Cresswell S, Johns K, Pal S, Dowe B, Tariq M, et al. Factors associated with racial/ethnic group-based medical mistrust and perspectives on COVID-19 vaccine trial participation and vaccine uptake in the US. JAMA Netw Open. 2021;4(5):e2111629. doi:10.1001/jamanetworkopen.2021.11629.34042990.
  • Reno C, Maietti E, Fantini MP, Savoia E, Manzoli L, Montalti M, Gori D. Enhancing COVID-19 vaccines acceptance: results from a survey on vaccine hesitancy in Northern Italy. Vaccines (Basel). 2021;9(4). doi:10.3390/vaccines9040378.33924534.
  • Barriere J, Gal J, Hoch B, Cassuto O, Leysalle A, Chamorey E, Borchiellini D. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673–74. doi:10.1016/j.annonc.2021.01.066.33529740.
  • Shen S-T A total of 84.529 million doses of COVID-19 vaccines have been inoculated nationwide. People’s Daily. 2021. accessed 2021 Jun 13. http://www.gov.cn/xinwen/2021-06/12/content_5617312.htm.
  • Interpretation of Adverse Reaction Surveillance Information of National COVID-19 Vaccination. Chinese center for disease control and prevention 2021. accessed 2021 Jun 13. http://www.chi-nacdc.cn/jkzt/ymyjz/ymyjjz_6758/202105/t20210528_230908.html
  • Monin L, Laing AG, Munoz-Ruiz M, McKenzie DR, Del Molino Del Barrio I, Alaguthurai T, Domingo-Vila C, Hayday TS, Graham C, Seow J, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021;22(6):765–78. doi:10.1016/S1470-2045(21)00213-8.33930323.
  • Waissengrin B, Agbarya A, Safadi E, Padova H, Wolf I. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors. Lancet Oncol. 2021;22(5):581–83. doi:10.1016/S1470-2045(21)00155-8.33812495.
  • MacDonald NE; Hesitancy SWGoV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.25896383.
  • Costantino A, Topa M, Roncoroni L, Doneda L, Lombardo V, Stocco D, Gramegna A, Costantino C, Vecchi M, Elli L. COVID-19 vaccine: a survey of hesitancy in patients with celiac disease. Vaccines (Basel). 2021;9(5). doi:10.3390/vaccines9050511.34065654.
  • Dzieciolowska S, Hamel D, Gadio S, Dionne M, Gagnon D, Robitaille L, Cook E, Caron I, Talib A, Parkes L, et al. Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: a multicenter survey. Am J Infect Control. 2021;49(9):1152–57. doi:10.1016/j.ajic.2021.04.079.33930516.
  • Puteikis K, Mameniskiene R. Factors associated with COVID-19 vaccine hesitancy among people with epilepsy in Lithuania. Int J Environ Res Public Health. 2021;18(8):4374. doi:10.3390/ijerph18084374.33924140.
  • Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, Ugurlu S, Tabak F, Hamuryudan V, Seyahi E. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int. 2021;41(6):1105–14. doi:10.1007/s00296-021-04841-3.33779780.
  • Kelkar AH, Blake JA, Cherabuddi K, Cornett H, McKee BL, Cogle CR. Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar. Healthcare (Basel). 2021;9(3). doi:10.3390/healthcare9030351.33808758.
  • Villarreal-Garza C, Vaca-Cartagena BF, Becerril-Gaitan A, Ferrigno AS, Mesa-Chavez F, Platas A, Platas A. Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol. 2021;7(8):1242. doi:10.1001/jamaoncol.2021.1962.34110371.
  • Angrini M, Varthaman A, Garcia-Verdugo I, Sallenave JM, Alifano M, Cremer I. To vaccinate or not: influenza virus and lung cancer progression. Trends Cancer. 2021;7(7):573–76. doi:10.1016/j.trecan.2021.02.006.33712391.
  • Chen KY, Wu SM, Liu JC, Lee KY. Effect of annual influenza vaccination on reducing lung cancer in patients with chronic obstructive pulmonary disease from a population-based cohort study. Medicine (Baltimore). 2019;98(47):e18035. doi:10.1097/MD.0000000000018035.31764822.
  • Korompoki E, Gavriatopoulou M, Kontoyiannis DP. COVID-19 vaccines in patients with Cancer – a welcome addition, but there is need for optimization. JAMA Oncol. 2021;7(8):1113. doi:10.1001/jamaoncol.2021.1218.3398337.